Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Journal of the National Cancer Institute
|
January 3, 1996
Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Childrens Cancer Group study
X O Shu, J A Ross, T W Pendergrass, et al.
Cancer
|
October 8, 1998
Epidemiology of osteosarcoma and Ewing's sarcoma in childhood: a study of 305 cases by the Children's Cancer Group
J D Buckley, T W Pendergrass, C M Buckley, et al.
Medical and Pediatric Oncology
|
January 1, 1992
Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: a report from the Childrens Cancer Study Group
S A Feig, M D Krailo, R E Harris, et al.
Transfusion
|
December 9, 2004
Prevention of immunization to D+ red blood cells with red blood cell exchange and intravenous Rh immune globulin
T A Nester, D M Rumsey, C C Howell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1987
Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy
T W Pendergrass, J M Milstein, J R Geyer, et al.
Medical and Pediatric Oncology
|
December 1, 1996
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group
S A Feig, M M Ames, H N Sather, et al.
The Journal of Bone and Joint Surgery. British Volume
|
January 1, 1982
Improved three-year disease-free survival in osteogenic sarcoma
W A Bleyer, J E Haas, P Feigl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 1999
Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group
G H Reaman, R Sposto, M G Sensel, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Journal of the National Cancer Institute
|
January 3, 1996
Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Childrens Cancer Group study
X O Shu, J A Ross, T W Pendergrass, et al.
Cancer
|
October 8, 1998
Epidemiology of osteosarcoma and Ewing's sarcoma in childhood: a study of 305 cases by the Children's Cancer Group
J D Buckley, T W Pendergrass, C M Buckley, et al.
Medical and Pediatric Oncology
|
January 1, 1992
Determination of the maximum tolerated dose of idarubicin when used in a combination chemotherapy program of reinduction of childhood ALL at first marrow relapse and a preliminary assessment of toxicity compared to that of daunorubicin: a report from the Childrens Cancer Study Group
S A Feig, M D Krailo, R E Harris, et al.
Transfusion
|
December 9, 2004
Prevention of immunization to D+ red blood cells with red blood cell exchange and intravenous Rh immune globulin
T A Nester, D M Rumsey, C C Howell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1987
Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy
T W Pendergrass, J M Milstein, J R Geyer, et al.
Medical and Pediatric Oncology
|
December 1, 1996
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group
S A Feig, M M Ames, H N Sather, et al.
The Journal of Bone and Joint Surgery. British Volume
|
January 1, 1982
Improved three-year disease-free survival in osteogenic sarcoma
W A Bleyer, J E Haas, P Feigl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 1999
Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group
G H Reaman, R Sposto, M G Sensel, et al.
Page
of 4